IV Formulations: Evidence and Regulation

Evidence-led writing for clinicians, pharmacists and licensed partners in Pakistan: what the published trials show, how DRAP registration and import work, and what to check before a product reaches a clinic.

Abstract wireframe visualisation of a molecular graph with warm copper highlights on a dark sandstone background
Clinical practice

IV Drip Therapy in Pakistani Clinics: Evidence, Oversight and Supplier Checks

No single Pakistani standard covers IV drip services, so clinics are judged under rules on licensing, medicines and advertising. What the 2025 and 2026 record shows, and the file a clinic should be able to produce.

EFBA Science Desk · 30 October 2026 · 8 min read
Abstract wireframe visualisation of a molecular graph with warm copper highlights on a dark sandstone background
Evidence

Glutathione Injection: Evidence, Safety Signals and How to Check a Product in Pakistan

What the trials of injected glutathione tested, the safety signals regulators have raised, and how to check whether a product on offer in Pakistan is registered with DRAP.

EFBA Science Desk · 30 October 2026 · 8 min read
Abstract wireframe visualisation of a molecular graph with warm copper highlights on a dark sandstone background
Regulation

DRAP Drug Registration and Import in Pakistan: A Guide for Importers and Distributors

The Drug Sale Licence, Form 5-F dossier, Registration Board, import conditions and limits on promotion: how an imported finished drug is registered in Pakistan, with a checklist for importers.

EFBA Science Desk · 30 October 2026 · 9 min read